Otsuka Holdings Yönetim

Yönetim kriter kontrolleri 3/4

Otsuka Holdings CEO'su Tatsuo Higuchi, Jul2008 tarihinde atandı, in görev süresi 16.33 yıldır. şirketin hisselerinin 0.031% doğrudan sahiptir ve bu hisselerin değeri ¥ 1.59B dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.8 yıl ve 6.7 yıldır.

Anahtar bilgiler

Tatsuo Higuchi

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	16.3yrs
CEO sahipliği	0.03%
Yönetim ortalama görev süresi	2.8yrs
Yönetim Kurulu ortalama görev süresi	6.7yrs

Son yönetim güncellemeleri

Recent updates

Earnings Miss: Otsuka Holdings Co., Ltd. Missed EPS By 10% And Analysts Are Revising Their Forecasts

Nov 04

Otsuka Holdings Co., Ltd. Just Beat EPS By 57%: Here's What Analysts Think Will Happen Next

Aug 05

Getting In Cheap On Otsuka Holdings Co., Ltd. (TSE:4578) Might Be Difficult

Jul 14

Otsuka Holdings Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 02

Is There An Opportunity With Otsuka Holdings Co., Ltd.'s (TSE:4578) 24% Undervaluation?

Apr 20

Is Otsuka Holdings (TSE:4578) A Risky Investment?

Mar 15

CEO Tazminat Analizi

Tatsuo Higuchi'un ücretlendirmesi Otsuka Holdings'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	JP¥152b
Jun 30 2024	n/a	n/a	JP¥127b
Mar 31 2024	n/a	n/a	JP¥138b
Dec 31 2023	n/a	n/a	JP¥122b
Sep 30 2023	n/a	n/a	JP¥185b
Jun 30 2023	n/a	n/a	JP¥167b
Mar 31 2023	n/a	n/a	JP¥172b
Dec 31 2022	JP¥280m	JP¥156m	JP¥134b
Sep 30 2022	n/a	n/a	JP¥110b
Jun 30 2022	n/a	n/a	JP¥104b
Mar 31 2022	n/a	n/a	JP¥104b
Dec 31 2021	JP¥283m	JP¥156m	JP¥125b
Sep 30 2021	n/a	n/a	JP¥147b
Jun 30 2021	n/a	n/a	JP¥153b
Mar 31 2021	n/a	n/a	JP¥155b
Dec 31 2020	JP¥316m	JP¥156m	JP¥148b
Sep 30 2020	n/a	n/a	JP¥143b
Jun 30 2020	n/a	n/a	JP¥146b
Mar 31 2020	n/a	n/a	JP¥146b
Dec 31 2019	JP¥244m	JP¥156m	JP¥127b
Sep 30 2019	n/a	n/a	JP¥116b
Jun 30 2019	n/a	n/a	JP¥86b
Mar 31 2019	n/a	n/a	JP¥79b
Dec 31 2018	JP¥178m	JP¥156m	JP¥82b
Sep 30 2018	n/a	n/a	JP¥117b
Jun 30 2018	n/a	n/a	JP¥134b
Mar 31 2018	n/a	n/a	JP¥114b
Dec 31 2017	JP¥298m	JP¥157m	JP¥112b

Tazminat ve Piyasa: Tatsuo şirketinin toplam tazminatının JP pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.

Tazminat ve Kazançlar: Tatsuo 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Tatsuo Higuchi (74 yo)

16.3yrs

Görev süresi

JP¥280,000,000

Tazminat

Mr. Tatsuo Higuchi has been the President, Chief Executive Officer and Representative Director of Otsuka Holdings Co., Ltd. since July 2008. Mr. Higuchi has been the Chairman of Otsuka Pharmaceutical Co.,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Tatsuo Higuchi	CEO, President & Representative Director	16.3yrs	JP¥280.00m	0.031% ¥ 1.6b
Makoto Inoue	COO & Representative Director	less than a year	JP¥154.00m	0.0089% ¥ 451.7m
Yoshiro Matsuo	Executive Deputy President & Executive Director	2.7yrs	JP¥128.00m	0.012% ¥ 621.1m
Masayuki Kobayashi	Executive Director	7.7yrs	JP¥138.00m	0.014% ¥ 696.6m
Yuko Makino	CFO & Executive Director	6.7yrs	Veri yok	0.0041% ¥ 206.9m
Tomohiro Emura	Vice President of Investor Relations	less than a year	Veri yok	Veri yok
Akiko Ryu	Senior VP & Director of Human Resource Planning Department	2.8yrs	Veri yok	Veri yok
Noriko Tojo	Executive Director	6.7yrs	JP¥104.00m	0.011% ¥ 564.8m
Shuichi Takagi	Executive Director	5.7yrs	Veri yok	0.0054% ¥ 272.8m
Chiaki Sakurai	Senior Vice President of Nutraceutical Business	2.8yrs	Veri yok	Veri yok
Shigeko Takahashi	Senior VP and GM of Nutraceutical Business	2.8yrs	Veri yok	Veri yok
Manabu Kawata	Senior Vice President of Business Development Department	2.8yrs	Veri yok	Veri yok

2.8yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim: 4578 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Tatsuo Higuchi	CEO, President & Representative Director	16.3yrs	JP¥280.00m	0.031% ¥ 1.6b
Makoto Inoue	COO & Representative Director	4.7yrs	JP¥154.00m	0.0089% ¥ 451.7m
Yoshiro Matsuo	Executive Deputy President & Executive Director	no data	JP¥128.00m	0.012% ¥ 621.1m
Masayuki Kobayashi	Executive Director	7.7yrs	JP¥138.00m	0.014% ¥ 696.6m
Yuko Makino	CFO & Executive Director	6.7yrs	Veri yok	0.0041% ¥ 206.9m
Noriko Tojo	Executive Director	6.7yrs	JP¥104.00m	0.011% ¥ 564.8m
Shuichi Takagi	Executive Director	5.7yrs	Veri yok	0.0054% ¥ 272.8m
Ichiro Otsuka	Chairman	16.3yrs	JP¥240.00m	1.46% ¥ 74.0b
Yukio Matsutani	Independent Outside Director	8.7yrs	Veri yok	Veri yok
Ko Sekiguchi	Independent Outside Director	6.7yrs	Veri yok	Veri yok
Yozo Toba	Chairman of Audit & Supervisory Board Member	6.7yrs	Veri yok	0.0013% ¥ 65.9m
Yoshihisa Aoki	Independent Outside Director	5.7yrs	Veri yok	Veri yok

6.7yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 4578 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.7 yıldır).

Otsuka Holdings Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Otsuka Holdings Co., Ltd., Annual General Meeting, Mar 30, 2023

Recent updates

Earnings Miss: Otsuka Holdings Co., Ltd. Missed EPS By 10% And Analysts Are Revising Their Forecasts

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. to Report Fiscal Year 2024 Results on Feb 14, 2025

Otsuka Holdings Co., Ltd.'s (TSE:4578) Price In Tune With Earnings

Is Otsuka Holdings (TSE:4578) A Risky Investment?

Price target increased by 7.8% to JP¥7,914

Calculating The Intrinsic Value Of Otsuka Holdings Co., Ltd. (TSE:4578)

Otsuka Holdings Co., Ltd. Just Beat EPS By 57%: Here's What Analysts Think Will Happen Next

First half dividend of JP¥60.00 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Otsuka Holdings Co., Ltd. (TSE:4578) announces an Equity Buyback for 10,000,000 shares, representing 1.84% for ¥50,000 million.

Now 21% undervalued

Otsuka Holdings Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Getting In Cheap On Otsuka Holdings Co., Ltd. (TSE:4578) Might Be Difficult

Price target increased by 9.7% to JP¥6,823

Upcoming dividend of JP¥60.00 per share

Now 22% undervalued

Otsuka Holdings Co., Ltd. Provides Earnings Guidance for the Year 2026

Now 21% undervalued

Otsuka Holdings Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

New minor risk - Profit margin trend

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is There An Opportunity With Otsuka Holdings Co., Ltd.'s (TSE:4578) 24% Undervaluation?

Final dividend of JP¥60.00 announced

Is Otsuka Holdings (TSE:4578) A Risky Investment?

Otsuka Holdings Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Otsuka Holdings Co., Ltd. Announces Year-End Dividend for the Year Ended December 31, 2023, Payable on March 29 , 2024; Provides Second Quarter-End Dividend Guidance for the Fiscal Year 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Revises Dividend for the Full Year Ending December 31, 2023, Payable on March 29 , 2024

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023

Upcoming dividend of JP¥50.00 per share at 1.9% yield

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Otsuka Holdings Co., Ltd. to Report Fiscal Year 2023 Results on Feb 14, 2024

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

Now 21% undervalued

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Otsuka Holdings Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half of Fiscal Year 2023

Otsuka Pharmaceutical Co., Ltd. Announces Positive Results of Phase III Trial in Japan Showing Reduced Agitation in Patients with Alzheimer's Dia Treated with Brexpiprazole

Upcoming dividend of JP¥50.00 per share at 1.8% yield

Otsuka Holdings Co., Ltd. to Report Q2, 2023 Results on Jul 31, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Otsuka Holdings Co., Ltd., Annual General Meeting, Mar 30, 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Otsuka Holdings Co., Ltd. Provides Dividend Guidance for Fiscal Year Ending 2023

Otsuka Pharmaceutical Co., Ltd. (Otsuka) Files an Application in Japan for an Additional Indication for Rexulti

Now 23% undervalued after recent price drop

Otsuka Holdings Co., Ltd. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥50.00 per share

Now 21% undervalued

Otsuka Medical Devices Co., Ltd. and Recor Medical, Inc. Announce Submission of Application for Pre-Market Approval of the Paradise uRDN to the U.S. FDA

Otsuka Holdings Co., Ltd. Revises Consolidated earnings Guidance for the Fiscal Year Ending December 31, 2022

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Otsuka Holdings Co., Ltd. Revises Consolidated Earrings Guidance for the Fiscal Year Ending December 31, 2022

Otsuka Holdings Co., Ltd. to Report Q2, 2023 Results on Oct 31, 2022

U.S. FDA Acceptance of New Drug Application for Aripiprazole 2-Month by Otsuka America Pharmaceutical, Inc

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ended June 30, 2022

Price target increased to JP¥4,725

Otsuka Holdings Co., Ltd. to Report Q2, 2022 Results on Jul 29, 2022

Upcoming dividend of JP¥50.00 per share

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter of Fiscal Year Ending December 31, 2022; Provides Earnings Guidance for the Year Ending December 31, 2022

Otsuka Holdings Co., Ltd. to Report Q1, 2022 Results on May 13, 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter and Full Year of Fiscal Ending December 31, 2022

Otsuka Holdings Co., Ltd. Revises Earnings Guidance for the Fiscal Year 2021

Upcoming dividend of JP¥50.00 per share

Third quarter 2021 earnings released: EPS JP¥64.97 (vs JP¥75.52 in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥86.15 (vs JP¥90.54 in 2Q 2020)